Park Ha Biological Technology is trading at $2.71, up 5.59%, with no fresh company-specific catalyst identified for October 8, 2026.

  • The company’s press-release page lists October 2 as its latest release.
  • The Nasdaq was down 0.52%, so broader market sentiment does not clearly explain the gain.
  • No trading-volume figure is available in the supplied live data.